Shanghai Health Medical University Affiliated Zhoupu Hospital Successfully Completes One of China's First RhythPulse® Pulsed Field Ablation and Left Atrial Appendage Closure Combo Procedures
ShineyoMedical
Provider of Atrial Fibrillation Electrophysiology and Peripheral Vascular Intervention Solutions
'%20fill='%23FFFFFF'%3E%3Crect%20x='249'%20y='126'%20width='1'%20height='1'%3E%3C/rect%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
On April 17, 2025, the team led by Director Ning Zhongping from Zhoupu Hospital, affiliated with Shanghai University of Medicine & Health Sciences, successfully utilized ShineyoMedical's RhythPulse.®Pulsed Field Ablation Catheter was used to perform Pulsed Field Ablation (PFA) combined with Left Atrial Appendage Closure (LAAC) surgery on a patient with atrial fibrillation. This marks one of the first RhythPulse procedures in China.®Pulse Ablation Surgery. The successful implementation of the surgery marks that the Cardiology Department of Zhoupu Hospital has mastered another "new weapon" for the treatment of arrhythmia that is safe, fast, and effective, reaching a new level in cardiovascular interventional diagnosis and treatment, especially in the comprehensive management of atrial fibrillation!
Patient Overview
The patient was diagnosed with atrial fibrillation due to recurrent chest tightness, palpitations, and shortness of breath. The oral administration of antiarrhythmic drugs and anticoagulants showed poor efficacy, and the patient had a high risk of bleeding. After comprehensive evaluation, Director Ning Zhongping's team adopted the internationally advanced "one-stop" surgical solution, utilizing RhythPulse from ShineyoMedical (Shanghai Shineyo Medical Device Co., Ltd.).®Pulse Ablation Combined with Left Atrial Appendage Closure Effectively Addresses AF Symptoms and Stroke Prevention Challenges in One Procedure.
Surgical Procedure
Preoperative patients were excluded from thrombus by left atrial CT. During the operation, transesophageal echocardiography (TEE) was performed after general anesthesia to confirm once again that there was no thrombus in the left atrium and left atrial appendage before performing transseptal puncture under TEE. After completing the transseptal puncture, the RhythPulse system from ShineyoMedical was used.®A catheter (25mm circular diameter) was used for bilateral pulmonary vein isolation. After completing electrical isolation of the pulmonary veins, a left atrial appendage closure procedure was performed using the LACbes disc occluder, achieving perfect one-time placement to seal the left atrial appendage. The pulsed ablation operation and discharge time took only over 20 minutes, with the entire procedure proceeding smoothly without any abnormalities, and the surgery was successfully completed.
RhythPulse®Catheter Ablation in the Left Upper Pulmonary Vein
LACbes Perfectly Occludes the Left Atrial Appendage
About RhythPulse®-PFA System
ShineyoMedical's RhythPulse®-PFA system is the first approved system in China that integrates multi-channel, large focal points, and targeted ablation in a pulsed field ablation (PFA) system, primarily used for treating drug-refractory and recurrent atrial fibrillation and other types of rapid arrhythmias. Its core advantages include:
Large Focal Design:Using the world's first 10mm ring ablation catheter, a single discharge can cover a lesion area with a diameter of 10mm, improving the ablation efficiency by more than three times compared to traditional technology.
Targeted Ablation Technology:Equipped with an intelligent contact detection module, it monitors the contact status between the electrode and myocardial tissue in real time, reducing the risk of hemolysis caused by ineffective discharges, and decreasing postoperative plasma free hemoglobin content by 50%.
Excellent Clinical Validation:In the clinical trial of 133 cases, the immediate success rate was 100%, and the success rate of atrial fibrillation treatment at 12 months post-operation reached 85.07%, achieving internationally leading standards.
Introduction of Experts
Ning Zhongping
Zhoupu Hospital Affiliated to Shanghai Health Medical College
Director of Cardiology, Member of the Cardiovascular Physicians Branch of the Chinese Medical Doctor Association, Member of the Left Atrial Appendage Occlusion Working Committee of the Heart Rhythm Society of the Chinese Medical Association, Secretary of the Left Atrial Appendage Group of the Chinese Heart Rhythm Society (CHRS), Standing Committee Member of the First Left Atrial Appendage Working Committee of the China Atrial Fibrillation Center Alliance, Member of the Cardiovascular Health Medicine Branch of the China International Medical Exchange Association, Member of the Cardiac Rehabilitation Management Committee of the Chinese Hospital Association, Deputy Chairman of the Cardiovascular Disease Specialized Committee of the Pudong New Area, Chairman of the Electrocardiogram Specialized Committee of the Pudong New Area; Recipient of Shanghai's "First Regional Famous Doctor," Winner of the Pudong New Area "May 1st" Labor Medal, and 2020 "Pudong Craftsman."
One of the early pioneers in cardiac interventional treatment in China, with profound expertise in coronary artery disease intervention, pacemaker therapy, structural heart disease intervention, and arrhythmia intervention. Has cumulatively performed nearly 20,000 cardiac interventional surgeries, over 800 cryoablation procedures for atrial fibrillation, and more than 1,800 left atrial appendage closure procedures. Has guided dozens of hospitals in China in performing atrial fibrillation ablation and left atrial appendage closure surgeries. Currently serves as a global training expert for cryoballoon ablation of atrial fibrillation and left atrial appendage closure. Has received two third prizes for provincial scientific and technological progress awards, one first prize and one third prize for municipal scientific and technological progress awards, published over 30 papers, and led or participated in more than 10 research projects.